Allaire Laura, Block Astrid, Paul Steven M, Hammer Marilyn J, Conley Yvette P, Cooper Bruce A, Levine Jon D, Miaskowski Christine
Laura Allaire.
Astrid Block.
Oncol Nurs Forum. 2024 Dec 12;52(1):23-40. doi: 10.1188/25.ONF.23-40.
To determine clinically meaningful cut points for the Herth Hope Index and evaluate for differences in demographic and clinical characteristics, as well as stress, resilience, and coping, between patients with lower versus higher levels of hope.
SAMPLE & SETTING: Outpatients with cancer receiving chemotherapy (N = 1,295).
METHODS & VARIABLES: Patients completed the Herth Hope Index, Multidimensional Quality of Life Scale-Patient Version, and stress, resilience, and coping measures prior to their second or third cycle of chemotherapy.
Optimal cut points for the Herth Hope Index were 40 or less (i.e., lower level of hope) and greater than 40 (i.e., higher level of hope). The Lower Hope group had a higher comorbidity burden and lower functional status.
Clinicians can use this information to educate patients about interventions that can decrease stress and improve their coping abilities. Patients with cancer may benefit from having conversations with clinicians that authentically convey prognosis and provide a realistic sense of hope.
确定赫思希望指数具有临床意义的切点,并评估希望水平较低与较高的患者在人口统计学和临床特征、压力、心理弹性及应对方式方面的差异。
接受化疗的癌症门诊患者(N = 1295)。
患者在接受第二轮或第三轮化疗前完成赫思希望指数、多维生活质量量表患者版以及压力、心理弹性和应对方式测量。
赫思希望指数的最佳切点为40及以下(即希望水平较低)和大于40(即希望水平较高)。希望水平较低组的合并症负担更高,功能状态更低。
临床医生可利用这些信息对患者进行教育,使其了解可减轻压力并提高应对能力的干预措施。癌症患者可能会从与临床医生进行的真实传达预后并提供现实希望感的谈话中受益。